AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
112 hedge funds and large institutions have $806M invested in Avadel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 99 → 112 (+13)
2.73% more ownership
Funds ownership: 60.85% → 63.57% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
112
Holding in Top 10
6
Calls
$15.6M
Puts
$4.96M
Top Buyers
| 1 | +$26.3M | |
| 2 | +$18.2M | |
| 3 | +$9.18M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$5.72M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$4.08M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$8.18M | |
| 3 | -$4.75M | |
| 4 |
D.E. Shaw & Co
New York
|
-$4.14M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.6M |